Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 409 of 6351
-
Can big data defeat the ICU's deadliest foe?
Knowledge-focused By invitation onlySepsis is a life-threatening organ dysfunction caused by a dysregulated host immune response to infection, and remains the leading cause of death in critical care medicine worldwide. According to the 2024 Global Burden of Disease data, there are 48.9 million new cases and 11 mill…
Sponsor: Beijing Chao Yang Hospital • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New lung cancer drug shows promise in early trial
Disease control Recruiting nowThis study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well it works when given alone or with chemotherapy. The study is for adults with early stage or locally advanced non-small cell lung cancer (NSCLC) that may or …
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase II study. It Aims aims to evaluate the efficacy and safety of different doses of SYH2059 tablets compared with placebo in adult patients with IPF, observe the PK profile of SYH2059 tablets in adult IPF pati…
Phase 2 • Sponsor: InnovStone Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New Self-Sampling and digital colposcopy could speed up cervical cancer detection
Diagnosis Not yet recruitingThe PRIORITY study is a prospective, multicenter observational study designed to evaluate an integrated diagnostic model combining extended molecular self-sampling and digital colposcopy supported by telemedicine for the prioritization of women at risk of cervical cancer. The st…
Sponsor: Pontificia Universidad Catolica de Chile • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
Sound waves and bubbles take on stubborn joint infections
Disease control Recruiting nowPatients with an infected knee replacement will receive their standard of care surgical treatment of the infection, with and without additional ultrasound microbubble treatment (randomly divided 50/50 in the active and control groups). Subjects in the active group will receive a …
Phase 2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug combo aims to shrink advanced stomach tumors
Disease control Not yet recruitingThis study is a multicenter,open-label,randomized, phase II clinical study conducted in China. The purpose of this study is to evaluate the efficacy of SKB315 plus PD-1 inhibitor ±capecitabine in patients with Unresectable Locally Advanced or Metastatic Gastric or Gastroesophagea…
Phase 2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New injection aims to shed pounds: phase 2 trial launches
Disease control Recruiting nowThis study is open to adults between 18 and 74 years of age and who have a body mass index (BMI) of 30 kg/m2 or more, or a BMI of 27 kg/m2 or more and at least 1 health problem related to their weight. People who have previously not managed to lose weight by changing their diet c…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo aims to tame liver side effects of cancer immunotherapy
Disease control Not yet recruitingThis phase II study evaluates whether early treatment with mycophenolate mofetil (MMF) plus prednisone improves liver inflammation caused by immune checkpoint inhibitors. The study includes patients who develop moderate to severe immune-related hepatitis after receiving PD-(L)1 o…
Phase 2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Texts that could transform trans teen sexual health
Prevention Not yet recruitingTransgender and gender-diverse young people who were assigned female at birth (AFAB), including transgender boys, nonbinary youth, and others, face real sexual health disparities. Existing pregnancy and HIV prevention programs are designed for cisgender girls and do not meet the …
Sponsor: Center for Innovative Public Health Research • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
New drug duo aims to outsmart resistant lymphoma
Disease control Not yet recruitingThis prospective, open-label, phase 2 study will evaluate the efficacy and safety of lisaftoclax in combination with pirtobrutinib in adults with relapsed or refractory mantle cell lymphoma following failure of prior BTK-targeted therapy. The study includes two cohorts. Cohort 1…
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo attack on untreatable liver cancer shows promise in early trial
Disease control Not yet recruitingPurpose: This phase II clinical trial evaluates whether a combination of liver-directed local therapies (HAIC and DEB-TACE) with immunotherapy (toripalimab) and targeted therapy (lenvatinib) is safe and effective for patients with unresectable intrahepatic cholangiocarcinoma (a t…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a targeted pill tame a rare immune disease?
Disease control Not yet recruitingThis single-center, prospective, interventional phase 2 study evaluates a response-adapted treatment strategy for patients aged 10 years and older with histologically confirmed Langerhans cell histiocytosis requiring systemic therapy. All participants receive six 35-day cycles of…
Phase 2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can imagining movement supercharge robot hand therapy for stroke recovery?
Disease control CompletedLoss of upper extremity and particularly hand function after stroke reduces independence in daily activities such as eating, dressing, and personal care. Robot-assisted hand rehabilitation provides repetitive, intensive, and task-oriented practice that supports motor learning, de…
Sponsor: Uskudar University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Choice of location may boost HIV prevention persistence
Prevention Not yet recruitingPrEP4U is designed as a pragmatic, randomized implementation trial to test strategies that could directly inform real-world roll-out of lenacapavir. By integrating: * Same-day initiation based on rapid HIV testing, and * Choice of follow-up delivery location (home, community, or…
Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
A simple breath test could spot lung infections in minutes
Diagnosis Not yet recruitingLower respiratory tract infections (LRTIs) remain a major global health burden, with diagnosis often challenged by clinical heterogeneity, overlapping symptoms, difficulty in obtaining quality biological specimens and limitations of conventional microbiological testing. Exhaled b…
Sponsor: Hopital Foch • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
Experimental fusion protein aims to re-engage immune system against tough esophageal cancer
Disease control Not yet recruitingEffective later-line treatment options remain an unmet medical need for patients with advanced esophageal squamous cell carcinoma (ESCC) whose disease has progressed after prior immunotherapy, particularly given the widespread use of immunotherapy in the first-line setting. This …
Phase 2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Why some Never-Smokers get lung cancer: a new study investigates
Knowledge-focused Recruiting nowThe researchers are doing this study to learn more about factors that may increase the risk of lung cancer in people who have never smoked. This information may help predict which people who have never smoked may be more likely to get lung cancer.
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Smarter heart pacing could cut hospital stays for heart failure patients
Disease control Not yet recruitingThe goal of this observational study is to evaluate the long-term clinical outcomes of physiologic cardiac resynchronization therapy (CRT) using conduction system pacing strategies compared with conventional biventricular CRT in patients with heart failure with reduced ejection f…
Sponsor: University of Pecs • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug aims to calm severe eczema without steroids
Disease control Recruiting nowThis is an interventional, randomized, parallel group, treatment, Phase 3, double blind study to assess the effect of Rezpegaldesleukin in participants 12 years of age or older with moderate to severe atopic dermatitis, as compared to placebo. The estimated participant overall d…
Phase 3 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a safer nerve block match the gold standard for Post-Mastectomy pain?
Symptom relief Recruiting nowPostoperative pain management is crucial for patients undergoing mastectomy for breast cancer. Regional analgesia techniques, such as the Thoracic Paravertebral Block (TPVB), are commonly used to reduce pain and opioid consumption; however, TPVB carries potential risks, including…
Sponsor: Dharmais National Cancer Center Hospital • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC